Bruker Corp (NAS:BRKR)
$ 75.07 -0.75 (-0.99%) Market Cap: 10.91 Bil Enterprise Value: 12.03 Bil PE Ratio: 27.30 PB Ratio: 7.71 GF Score: 96/100

Bruker Corp at Citi Healthcare & Medtech Conference Transcript

Mar 02, 2023 / 02:30PM GMT
Release Date Price: $73.63 (+9.15%)
Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

All right. We can look to get started. So thanks, everyone, for being here. I'm Patrick Donnelly, the tools and diagnostics analyst here at Citi. Happy to have Gerald Herman, CFO of Bruker with us for this session. Gerald, thanks for being here.

Questions & Answers

Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

Maybe we can start, you guys reported the quarter pretty recently here, strong results, really nice guide for '23. Maybe just talk to the quarter quickly, kind of the moving pieces and then we can kind of get into orders in '23 and kind of move on from there.

Gerald N. Herman
Bruker Corporation - Executive VP & CFO

Sure. Well, thanks for inviting us. Happy to be here. It's always a pleasure to be in New York. I guess I'd say relative to the fourth quarter, a pretty solid performance across almost all of our end markets. We put up quite strong order bookings performance, in particular, in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot